whoslets

A Food and Drug Administration (FDA) dissection of three commonly prescribed drugs purchased from a Web site advertised as Canadian showed that so-called “Canadian Generics” bought from the Trap site were fake, substandard and potentially dangerous.

One was a controlled substance. In light of these findings, FDA reiterates its strong concerns about purchasing prescription drugs online from unknown sources.

FDA investigators recently purchased three commonly prescribed drugs from a Web site advertising “Canadian Generics,” which had been sending “spam” emails promoting its products. The products purchased were so-called “generic” versions of Viagra, Lipitor, and Ambien. None of the three products has a U.S.-approved generic version, and so all three drugs were unapproved.

“The test results of our analyses offer proof positive that buying prescription drugs online from unknown foreign sources can be a risky business. As was the case here, even where a website looks legitimate, FDA has clear evidence that the Web site is dispensing misbranded drugs that are not the same quality as those approved by the FDA for sale in the United States. Consumers who believe they are getting equivalent products from reputable sources are being misled and putting their health at risk,” said FDA Acting Commissioner Dr. Lester M. Crawford. “This firm shipped drugs that were the wrong strength, including some that were substantially super-potent and that pose real health risks as a result, drugs that didn’t dissolve properly, drugs that contained contaminants, and drugs that should not have been given because of potentially dangerous drug interactions.”

Ambien, a controlled substance (schedule IV), is approved for the short-term treatment of insomnia in the U.S. The product FDA obtained online contained too much active ingredient, including one tablet that was nearly double the labeled potency. Taking “superpotent” Ambien puts patients at risk for central nervous system depression, especially in elderly or debilitated patients.

The so-called “generic” Lipitor FDA purchased was subpotent and failed standard dissolution tests, providing on average only 57 percent of the active ingredient claimed on the label. It also failed FDA’s purity testing. Clinically, subpotent product could present a long-term risk for the various complications of high cholesterol, such as heart disease. In addition, the so-called “generic” Lipitor product was furnished to FDA’s online purchaser, even though the purchaser said that he was taking the antibiotic Erythromycin. Lipitor’s label warns against taking Lipitor and Erythromycin at the same time.

Viagra is sold in the U.S. to treat impotence. The so-called “generic” version of this product also contained too little of the active ingredient, failed the dissolution test, and had an unacceptable level of impurities. Although subpotent “generic” Viagra may not place patients at additional risk, the purchaser informed the firm in its on-line questionnaire that he was taking Erythromycin. Use of Viagra in patients taking Erythromycin is contraindicated.

comprar viagra

FDA continues to advise patients and consumers that they must use great care when purchasing prescription drugs online. Our evidence indicates that although a Web site may appear to be hosted by a reputable source and may look similar to other retail pharmacy Web sites, many of these sites in fact operate from outside the United States and are providing unapproved drugs from unreliable sources. The National Association of Boards of Pharmacy (NABP) has established a program called VIPPS designed to certify Web sites that meet industry standards. The Agency believes that consumers should look for participation in this type of certification program as one method to help minimize the risks of getting bad quality drugs from disreputable sources.

The FDA’s test results are summarized in a chart that can be accessed at: http://www.fda.gov/importeddrugs/chart071304.html. Additional information about buying drugs online is available at FDA’s website, http://www.fda.gov/oc/buyonline/default.htm.

Tumor-suppressor proteins work to inhibit tumor intumescence in our bodies and when they gain, they spare us a battle with cancer. But solitary such protein, menin, appears to pull someone’s leg a split name. Nonetheless menin is well-known for its ability to suppress endocrine tumors, researchers at Stanford University Group of Medicine obtain discovered that it is also a legend player in the advance of some forms of on the qui vive leukemia.

The researchers, who made the discovery in working with mouse cells, say this is the first time a tumor-suppressor protein has been found to have such a dramatic dual role. But there may be a silver lining in menin’s dark side - understanding the mechanism could open up new avenues of treatment for the very leukemias that menin promotes.

Normally menin binds with another protein, known as MLL, in the nucleus of a cell, where the two are part of a complex of proteins that promote proper cell growth. But when MLL is mutated, it becomes a cancer-promoting oncoprotein. Usually this would put the tumor suppressor and the oncoprotein in direct conflict, as each sought to overwhelm the other, but not so in cases of acute leukemia. “We’ve discovered a situation where they’re not antagonizing each other’s actions, they’re actually working together,” said Michael Cleary, MD, professor of pathology and of pediatrics and senior author of the paper published in the Oct. 21 issue of Cell.

When the blood system is functioning properly, the menin and the normal MLL proteins work together constructively, helping guide cells through all the stages of development from their beginnings as blood-forming stem cells to final maturation, or differentiation, into blood cells. But when MLL is mutated, the differentiation process stalls at an intermediate stage and the immature cells begin proliferating uncontrollably.

Given that menin is highly effective in suppressing endocrine tumors, Cleary and first author Akihiko Yokoyama, a postdoctoral scholar in pathology, suspected that MLL was somehow deactivating menin’s suppressive powers. They tested the theory with mouse cells in vitro by introducing the mutated MLL oncoprotein and letting leukemia begin to thrive. Yokoyama then genetically removed menin from the cancer cells.

If menin and MLL were struggling against each other, the researchers reasoned that removing menin would either have no effect on the rate of proliferation, or the leukemia would run even wilder, flourishing without restraint. But the leukemia ground to a halt.

“The cells actually stopped proliferating,” said Yokoyama, adding, “If you had to predict the outcome, you would’ve predicted exactly the opposite of what occurred.”

Even more unexpected was what happened next - the former cancer cells matured. Like juvenile delinquents steered away from a life of crime when a bad influence is removed, the immature blood cells not only ceased their bad behavior once the menin was gone, they resumed productive lives. They completed the differentiation process and became mature blood cells. The leukemia disappeared without a single cancer cell being killed.

Further work by Yokoyama established that menin was actively involved in promoting the acute leukemia, rather than simply being passive raw material for MLL to use. “This is the first example that we know of where an oncoprotein and a tumor-suppressor protein are physically working together to promote cancer,” said Cleary.

Exactly what causes menin to behave as it does in acute leukemia isn’t clear. What at first appears to be Jekyll-and-Hyde behavior may simply be a matter of slavish devotion to its mission, with the protein plying the only trade it knows regardless of whether its actions inhibit cancer or, in the case of acute leukemia, promote it.

Not knowing just how menin does what it does, the researchers said it’s difficult to speculate whether similar processes could be happening elsewhere in the human body. But the findings offer tantalizing possibilities for pursuing new treatments for MLL-associated acute leukemias, which make up between 5 and 10 percent of all leukemias in both adults and children. Acute leukemias associated with MLL oncoproteins are extremely aggressive and patients generally don’t respond well to conventional treatments.

But the stunning reversal of leukemia in the mouse cells when menin was removed offers clues for developing treatments. If the team’s findings can be applied to humans, “we would probably stop a leukemia dead in its tracks,” said Cleary. There’s a lot more that needs to be learned before that could be attempted, but Yokomama and Cleary are cautiously optimistic.

viagra comprar

“We’re chipping away at the molecular mechanism for how the MLL oncoprotein works,” said Cleary. “The more basic knowledge we have, the more chance we have of designing more effective and specific treatments.”

Other Stanford researchers involved in the study are Tim Somervaille, MD, PhD, postdoctoral scholar in pathology, and Kevin Smith, PhD, basic life science research associate in pathology.

http://www.med.stanford.edu/

The American Alliance for Microbiology will hold its 105th Prevailing Gathering in Atlanta, Georgia, June 5-9, 2005, at the
Georgia Era Congress Center. The meeting will part approximately 2,900 scientific presentations on topics spanning the
spectrum of the microbiological sciences. Microbiologists study living organisms and catching agents, and their operate is
ticklish to health, agriculture, the setting and biotechnology. Many accomplishments in the microbiological sciences have
significantly artificial our lives, such as the incident of treatments for contagious diseases, the retarding of food
spoilage, the deplete of microorganisms to bathe a exhaust up pollutants and basic knowledge of the nature of all living things.

Among the topics to be presented are:

– Emerging Infectious Diseases in 2005
– Microchips as microbe detectors
– Infections as a creator of chronic diseases
– New poop about bioterrorism readiness

More complicated information, including programs and abstract, will be available in primordial May. Preliminary programs and clip
registration materials are currently nearby and can be obtained by pursuit the ASM Responsibility of Communications or online at
asm.org/Media/index.asp?bid=2673. Additional press
materials can be found at this plot as they become available. CHOOSE NOTE: The homes deadline is April 29, 2005. While
media will be allowed to register for the meeting after that date, they devise be answerable because of arranging hotel
accommodations on their own.

Sweeping media facilities will be available and meeting registration is complimentary in the course of the media.

The ASM General Appointment Press Center order be located in Live A410 of the Georgia World Congress Center and command be artless
starting at 12:00 noon on Sunday, June 5. Programs, abstracts, news releases and poop on every side daily press conferences
will be available. All media representatives must be registered to attend sessions; registration is limited to a acme of
three individuals from a single outlet. Wish note that videotaping in session rooms is not allowed.

impotencia masculina

The ASM, headquartered in Washington, D.C., is the oldest and largest single biological membership organization with
take 44,000 members worldwide. Members work in different organizations, including tutelage (research institutions,
undergraduate and graduate institutions, and medical dental and veterinary schools), industry (pharmaceutical, rations and
agriculture, biotechnology, environmental, and pollution guidance companies and hospitals), and federal and report governments
(research laboratories and public health).

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American League for the sake Microbiology
http://www.asm.org

Looking for an anti wrinkle skin cream? Want to find the best one available? Well, if you’re anything like me, then you’ve probably tried a dozen different creams and were totally dissatisfied with the results.

Viagra

The truth is that there aren’t very many companies that use the quality of ingredients that have the ability to make a long-lasting impact on your skin.

Most companies use ingredients that are cheap and irritating (some have even been suspected of causing cancer, such as parabens), and their so-called “active” ingredients aren’t concentrated enough to have any effect. Not only that, but most companies don’t use formulations that allow the ingredients to absorb deep enough into the skin.

But, don’t give up hope, because there are small, specialized skincare companies who, in my opinion, make the best skin creams that I have ever used. These companies lead the pack in skincare research and use only the purest, most effective ingredients.

So, how does the best anti wrinkle skin cream stand apart from those “so-so” products? Well, it’s unique in the following ways:

- Contains no “questionable” or cheap ingredients — Many skincare companies use cheap, low-quality ingredients in their products, such as mineral oil, alcohols, and fragrances. These three are very common and also very bad for the skin, as they trap toxins, irritate, and dry the skin, allowing age spots and wrinkles to form prematurely.

The best anti wrinkle skin creams contain natural, rich moisturizers and plant waxes in the place of mineral oil, alcohols, and fragrances. These natural oils and waxes do not irritate or age the skin, but rather hydrate and soften the skin cells, and they do it much better than artificial moisturizers.

- Penetrates deeper layers of the skin — The number of skin layers a cream penetrates is based on how it was formulated to absorb into the skin. Many products contain ingredients with molecules too large to penetrate very deep.

The best skin products contain ingredients that have been re-formulated to break down the molecules as tiny as possible without losing the desirable properties. These re-formulated ingredients then have the power to penetrate many layers of skin, instead of just a few.

- Stimulates growth of new skin structure — To be effective, any anti wrinkle skin cream must stimulate the growth of new skin structures, such as collagen and elastin. This is very important to remember. Many people buy products containing collagen and think this will work to get rid of wrinkles, but it won’t. Collagen molecules are too large to be absorbed through the skin and cannot be re-formulated.

The best creams that I have used contain Functional Keratin, which is a unique type of keratin that has gone through special processing. Clinical studies have shown that products containing this keratin significantly decrease fine lines and wrinkles, because the keratin stimulates the body to ramp up its production of collagen and elastin. This is the best, and easiest, way to increase the amount of collagen in your skin.

To learn more about the unique properties of the best anti wrinkle skin cream, and where to find it, please visit my website.

Haley Hensley is very passionate about natural skin care and is dedicated to finding quality skin care products. Visit her website to learn about the anti wrinkle skin cream she recommends after extensive research: http://www.your-favorite-skin-site.com

More than 20 million men in the United States with a single signature park of inherited characteristics and mutations in mitochondrial DNA (mtDNA) are at significantly increased risk in return developing renal and prostate cancers, according to investigation at Emory University.

The findings will be presented at the 96th Annual Meeting of the American Association for Cancer Research by John A. Petros, MD, associate professor of urology at Emory University School of Medicine, its Winship Cancer Institute, and the Atlanta VA Medical Center.

Mitochondrial DNA, which contains a small number of genes inherited mainly from the mother, is found in the hundreds of mitochondria located in the cytoplasm outside of each cell’s nucleus. The mitochondria often are called the “powerhouse” of the cell because they produce about 90 percent of the body’s energy.

In a study comparing mtDNA of men from the general population to mtDNA of men with renal and prostate cancer, Dr. Petros found that only 9.6 percent of the general population of Caucasian Americans had mtDNA in haplogroup U, while 16.7 percent of prostate cancer patients and 20.7 percent of renal cancer patients exhibited the haplogroup U signature. A haplotype is a combination of variations in a gene.

In addition to the variations in haplogroup U, Dr. Petros also found that 12 percent of prostate cancer patients had several missense mutations in a mitochondrial gene called cytochrome C oxidase subunit I (COI) gene compared to less than 2 percent of patients with negative biopsies for prostate cancer. Missense mutations in genes lead to amino acid substitutions in the protein encoded by the gene.

“This is convincing evidence that mitochondrial variations and mutations play an important role in prostate and renal cancers,” Dr. Petros said. “This is the first evidence that individuals who inherit these mutations are at increased risk of developing prostate cancer later in life. Mitochondrial genotyping has the potential of identifying this large number of at-risk individuals so that screening can be initiated for early detection and prevention.”

http://www.medweb.emory.edu/MedWeb

Clioquinol, an antibiotic that was banned for internal partake of in the Collaborative States in 1971 but is tranquillity used in topical applications, appears to block the genetic vigour of Huntington’s disease in mice and in chamber culture, according to a study reported by San Francisco VA Medical Center (SFVAMC) researchers.

The study, led by principal investigator Stephen M. Massa, MD, PhD, a neurologist at SFVAMC, was reported in the August 16, 2005 issue of Proceedings of the National Academy of Sciences.

Huntington’s disease is a hereditary, degenerative, and ultimately fatal disease of the brain that causes changes in personality, progressive loss of memory and cognitive ability, and a characteristic uncontrolled jerking motion known as Huntington’s chorea. There is no known cure or effective treatment. A person who carries the mutant Huntington’s gene may pass it on unknowingly because the disease often manifests in early to late middle age after the carrier’s children have already been born.

During the course of the disease, the Huntington’s gene causes the production of a toxic protein, mutant huntingtin, in neurons (brain cells). Eventually the protein kills the neurons, causing the disease’s degenerative effects.

In Massa’s study, Clioquinol appeared to interrupt the production of mutant huntingtin. In the first part of his study, Massa and his research team tested the effect of Clioquinol on neurons in cell culture that contained a form of the mutant Huntington’s gene. “We found that not only did cells look better and survive a bit longer when exposed to the drug, but they also seemed to make less of the toxic protein,” observed Massa, who is also a clinical assistant professor of neurology at the University of California, San Francisco (UCSF).

Based on the in vitro results, Massa decided to test the drug in vivo, on mice bred to express the toxic huntingtin protein. The mice were given approximately 1 milligram of Clioquinol per day in water. After eight weeks of treatment, they had accumulated four times less toxic protein in their brains than control mice given water alone. The experimental animals lived 20 percent longer than the control animals, did better on tests of motor coordination, and had less weight loss.

“It’s a limited study, in that we used the same drug dose on all the animals as opposed to comparing different doses, but fairly convincing,” Massa concluded. “Together, the in vitro and in vivo results suggest that Clioquinol has an effect of decreasing the symptoms of Huntington’s, its pathology, and perhaps even the actual production of the toxic protein.”

However, he noted, “the drug’s mechanism of action remains unclear.” The clearer the mechanism of the drug, he explained, the better the chance that researchers might eventually be able to create a medication that is both safe and effective.

Like some other antibiotics, Clioquinol is known to be a chelator — that is, it binds metals in body tissues, particularly copper and zinc, and removes them when it is excreted. Massa and other researchers believe that this chelation effect may interfere with production of the mutant huntingtin protein in some way. “But there are still a couple of explanations we need to rule out,” he said.

To that end, Massa’s next studies will involve the creation of an in vitro system in which toxic and non-toxic forms of huntingtin are made in the same cell. He and his team will then evaluate the effects of Clioquinol on several phases of protein synthesis within the cell. Massa hopes these experiments will confirm initial indications that Clioquinol preferentially interferes with synthesis of the toxic form of the protein. “Then we can move on to trying to isolate the actual mechanism of the drug,” he predicted.

“However,” Massa cautioned, “the record of successfully translating drugs from animal to human use is not good.”

Clioquinol has shown promise as a potential treatment for Alzheimer’s disease in recent studies in mice and humans. Apparently through chelation, it interferes with the creation of beta-amyloid plaque in the brain, which has been implicated in the progression of Alzheimer’s symptoms.

Currently, Clioquinol is banned for internal use in many countries because of its side effects. In Japan in the late 1950s and 60s, the drug was found to cause a neurologic condition called subacute myelo-optico-neuropathy (SMON), with symptoms including visual loss, muscle weakness, and numbness, in several thousand people. However, noted Massa, the doses given in current clinical trials are much smaller than were commonly prescribed in Japan. In addition, he explained, it has been found that vitamin B12, when taken along with the drug, protects against its potential toxic effects.

Co-authors of the study were Trent Nguyen, PhD, and Aaron Hamby, BS, of SFVAMC and UCSF.

http://www.ucsf.edu/

“Size Matters: The Number of Prostitutes and the Extensive HIV/AIDS Pandemic,” PLoS One: John Talbott of Africans Against AIDS used cross-boonies linear and multiple regressions based on chic UNAIDS data to detect that the number of female commercial shagging workers as a percentage of the adult female people is surely correlated with HIV/AIDS prevalence nationwide. Talbott also establish that literacy levels among women, differences in literacy levels between genders and inequalities in income also are positively correlated with HIV/AIDS prevalence — a pronouncement that confirms the results of previous studies. In additionally, Muslims as a percentage of the population — which is correlated with spear circumcision rates and previously has been found to negatively correlate with HIV/AIDS prevalence — is not significant when the percentage of commercial sex workers is captivated into account, according to Talbott.

The study’s findings provide “strong trace that when conducted decently, cross-mountains regression statistics does not tolerate the theory that male circumcision is the cue to slowing the AIDS pestilence,” Talbott writes. He adds that the tot up of HIV-peremptory commercial sex workers is a “highly significant and robust” method of explaining nationwide HIV primacy. This method also provides an “explanation … since why Africa has been hit the hardest by the AIDS pandemic and why there appears to be very itsy-bitsy correlation between” HIV/AIDS commonness and country wealth, according to Talbott (Talbott, PLoS A specific, 6/20).

“Reprinted with indulgence from http://www.kaisernetwork.org. You can hold the absolute Kaiser Constantly Health Game plan Report, search the archives, or cypher up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a untie advice of The Henry J. Kaiser Family Inauguration . © 2005 Monitory Board Company and Kaiser Family Foundation. All rights strait-laced.

Attention Deficiency Disorder is often misdiagnosed in children and on occasion in adults. In recent years Attention Shortfall Disorder or COUNT UP has been found in more children and adults because it is finally being recognized in the medical community by more teachers and surrounding adults.

ADD used to be considered a childhood disorder that would fade with adulthood; however, this is not the case. As more research studies are being performed on ADD other causes are being found. This is not to say that every child suspected of being ADD is actually going to be positive for the disorder. There are some children who have a more hyperactive lifestyle. They tend not to be able to sit still or pay attention in class, but it has more to do with being an active individual than the typical child.

There are several thoughts as to what causes Attention Deficit Disorder. Researchers believe that it is caused by heredity or pregnancy habits. Researchers also believe it could be caused by a distorted brain function. In other words, with ADD patients brain scans have shown that neural paths can be interrupted so that the messages don’t get to the proper source which creates more impulsive, disorganized and lack of attention type behaviors.

Heredity is a consideration because one in every four children with the condition has at least one family member with ADD. It could be an older sibling and younger sibling shares the traits, or the mother or father. However, this research has largely been underdeveloped and there are no concrete answers.

Pregnancy habits have also been blamed for the Attention Deficit disorder in children. Smoking or alcohol is thought to be a cause during pregnancy for ADD. It could also be a childhood exposure. For example chemicals that a child is exposed to can be toxic. These chemicals then create an issue with the proper growth of cells in the body and create their own chemical imbalance.

As of yet the exact reasons or causes for Attention Deficit Disorder are not known. There are ways to work with ADD that can benefit a child or adult. As a person working with a sufferer of ADD it is also imperative that you understand what you may need to change to make their environment easier for them. In the past ADD sufferers have been placed in remedial classes because they are difficult to teach, but this is wrong and unnecessary.

Those with Attention Deficit Disorder do need to be reminded to stay on task more often than other children or adults. By understanding the disorder, it is easier to outline tasks for completion and make sure the student will stick to the assignment. Often breaking up tasks viewed as mundane, for these students such as reading with more active studies will help the individual stay on task. There are natural and medical remedies that can be sought as well to help. Medicines will usually calm the individual down and should only be used for severe cases of Attention Deficit Disorder. For more insights and additional information about Attention Deficit Disorder please visit our web site at http://www.all-about-add-adhd.com

Thermo Fisher Scientific, Inc., the globe leader in serving science, announced today the too of its MBP brand PROFESSION obstacle tips in two new packaging configurations. The ART Reload Technique combines separately packaged impediment douceur reload inserts with space-saving hinged racks, offering an innovative and environmentally-pally option to expected tip packaging.

This sterile, barrier tip reload system features a “push down” blister tub that clips the inserts securely into the hinged rack without exposure to the environment for a wholly contamination-at liberty delivery of the pipette tips into the gift racks. Effortless removal of the inserts from the racks after tips cause been used makes this space-saving reload system a compact alternative. Altogether reload the existing rack with late-model inserts. Purchasing inexpensive insubstantial hinged racks allows for simple conversion to the blister tubs, while covers may be against as hinged or heave up exalt-touched in the head style, to fit specific laboratory needs. The Reload System components utilize recycled materials to package virgin polypropylene obstacle tips, making the Reload Methodology a contamination-free, environmentally-friendly pre-eminent.

For more advice about the new CUNNING Reload System, content smite http://www.mbpinc.com.

Molecular BioProducts is part of Thermo Fisher Scientific, the world gaffer in serving science.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the domain healthier, cleaner and safer. With annual revenues of $10.5 billion, we have more than 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, into institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two prime brands, Thermo Precise and Fisher Detailed, we serve clear up analytical challenges from habit testing to complex investigating and recognition. Thermo Scientific offers customers a complete latitude of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a unbroken portfolio of laboratory furnishings, chemicals, supplies and services used in healthcare, painstaking research, safety and course of study. Together, we offer the most convenient purchasing options to customers and continuously appreciation our technologies to accelerate the pace of well-ordered discovery, intensify value because customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com.

Thermo Fisher Scientific acquired Molecular BioProducts (MBP), a best manufacturer of exalted quality pipette tips within the liquid handling market, who has made continual innovations and patents focused in the area of controlling contamination associated with handling samples in the molecular biology workplace.

Thermo Fisher Thorough Inc

Lacing wigs and spike fronts are the hottest ticket in default there. Lace wigs were from the word go on the contrary found in the theatre, the gleaming screen or on those who had the connections to be experiencing one made as regards them. Lace wigs and lace fronts have recently been seen on the streets since the repute of some well seen celebrities who directly bear up the wigs and mesh front additions.

A lace wig is truly the ultimate for any wig wearer. They are different from wigs as we generally know them because they are usually made or at least “tailored� to fit the individual. A lace wig is made completely of a soft French or Swiss lace in several sections and the wig maker will take darts in the lace to make the material contour the head and because of this it is possible to get a glove tight fit for the wearer. During the process of tailoring the wig base the wig maker will take into effect the finished hair style to be sure that the lace is place so the hair can be ventilated / tied into the base going in the correct direction for the finished style.

This is especially important in the top and frontal area as this is where the hair must flow naturally and the way the lace is configured hair direction will be affected if the lace is not placed correctly. Once the wig maker has the cap completed they can do a final fitting to be sure the fit is correct and the front is smooth and tight. If adjustments need to be done this is the time to do it and a final fitting can be done just to check. Once the cap is finished the wig maker can now begin ventilating the hair into the base. This is done with a hooked ventilating needle that can be gauged to pick up as many hairs as needed for a section of the wig. For example in the back and side areas the wig maker may use a needle that picks up 2 to 4 hairs for the knot. This allows for volume without having to fill in quite so many holes in the lace. The wig maker will usually start at the nape area and work up on the back of the wig followed by the sides and then working on the top. Once the wig maker gets to the top and front area they will usually switch their ventilating needle to only pick up one hair for each knot. This allows the wig maker to make very small tight knots that are virtually impossible to be seen. The real art for the wig maker is of course the frontal area. The single hair knots, placement and hair direction has to look and move like natural hair and should not be noticeable to the eye. Once a lace wig is completed, dressed or styled and placed on the head a small amount of lace adhesive is placed on the skin where the edge of the lace will sit, allowed to get tacky and then the lace is pressed into the adhesive where it disappears into the skin. Once the adhesive is completely dry normal daily make up can be applied and the wearer is ready to go.

About the Author

Hair-necessities has provided Hair Pieces services directly to consumers for years, and is an online leader in the hair replacement industry. Visit www.hair-necessities.com to learn more about the variety of hair systems available!